Thursday, March 15, 2018
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, today announced that it has received 510(k) clearance from US regulators for a significant improvement to its STERIZONE® VP4 Sterilizer. The cleared change can improve the customer installation process and reduce start-up costs by significantly reducing the oxygen supply requirements for the system.
"We are excited to incorporate this new feature to our STERIZONE® VP4 Sterilizer", said TSO3 President and CEO R.M. (Ric) Rumble. "The improvement now makes the installation of our device more cost-effective, further solidifying its position as the least expensive, on a cost per item sterilized basis, low temperature sterilizer available today relative to legacy hydrogen peroxide-based sterilizers."
All of the Company's new STERIZONE® VP4 Sterilizers, along with any upgraded units in existing inventories, can now incorporate this new feature and several other additional customer improvements intended to improve the user experience.
